3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide | CAS:97-35-8

We serve 3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide CAS:97-35-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide

Chemical Name: 3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide
CAS.NO:97-35-8
Synonyms:Fast Red Itr Base;3-amino-N,N-diethyl-4-methoxy-Benzenesulfonamide
Molecular Formula:C11H18N2O3S
Molecular Weight:258.33700
 
Physical and Chemical Properties:
Density:1.205g/cm3
Boiling point:410.6ºC at 760mmHg
Melting point:102-105°C
Flash point:202.1ºC
Index of Refraction:1.547
 
Specification:
Appearance:White powder
Purity:≥98.0%
 
Packing: 25kg drum
Storage:Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Flammables-area.
Application:Mainly used in the manufacture of organic pigments.



Contact us for information like 3-Amino-N,N-diethyl-4-methoxybenzenesulfonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-amino-N,N-diethyl-4-methoxy-Benzenesulfonamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Fast Red Itr Base Use and application,Fast Red Itr Base technical grade,usp/ep/jp grade.


Related News: The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China.7-chloro-1-heptanol acetate manufacturer The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China.4'-N-OCTYLACETOPHENONE supplier Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.Diallyl sulfide vendor Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.